Identification of a novel frameshift mutation in the  gene as the cause of muscular dystrophy in a Norfolk terrier dog by unknown
Jenkins and Forman Canine Genetics and Epidemiology  (2015) 2:7 
DOI 10.1186/s40575-015-0019-4SHORT REPORT Open AccessIdentification of a novel frameshift mutation in
the DMD gene as the cause of muscular
dystrophy in a Norfolk terrier dog
Christopher A Jenkins* and Oliver P FormanAbstract
Background: A Norfolk terrier was referred to the Animal Health Trust neurology department with suspected
dystrophin-deficient muscular dystrophy (DD-MD), which was confirmed by clinical workup and immunohistochemistry.
Findings: Exon resequencing of the canine Duchenne Muscular Dystrophy (DMD) gene was undertaken to screen
for potential disease causing mutations. The sequence data generated from all coding DMD exons revealed a 1 bp
deletion in exon 22, causing a frameshift and premature termination of the coding sequence. Gene expression
analysis indicated reduced levels of dystrophin transcript in the DD-MD case and western blot confirmed the
absence of full length protein.
Conclusions: The finding represents a novel mutation causing DD-MD in the dog.
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In healthy skeletal muscle the dystrophin protein pro-
tects cells against damage when contracting during
movement. In dystrophin deficient muscular dystrophy
(DD-MD) the absence of dystrophin results in damage
to the muscle. This leads to loss of mobility and reduced
life expectancy.
A six month old male Norfolk terrier was referred to
the Animal Health Trust neurology department, and was
confirmed as having DD-MD. This was the first time the
disease had been described in this breed. The aim of this
study was to identify the genetic cause of the disease in
this dog.
The coding exons of the dystrophin gene (DMD) were
sequenced, in both the affected dog and its mother. A
variant in exon 22 was identified which was predicted to
result in the production of a truncated dystrophin pro-
tein. The lack of functional dystrophin in the affected
dog was confirmed through expression analysis.* Correspondence: chris.jenkins@aht.org.uk
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article, unless otherwise stated.In conclusion, this study identified a novel variant in
DMD, which is likely to be the cause of DD-MD in a
Norfolk terrier dog.Findings
Dystrophin-deficient muscular dystrophy (DD-MD) is an
X-linked disease in humans (Duchenne Muscular Dys-
trophy, DMD) and dogs [1]. In DD-MD the lack of func-
tional dystrophin protein causes advancing muscle
weakness, respiratory problems, and cardiomyopathy [2].
DD-MD is currently incurable, and the dog is an ideal
model for the disease because the canine phenotype is
very similar to that seen in humans [1]. In muscle dys-
trophin protects cells from shearing stress caused by
contraction [3]. The absence of dystrophin damages the
integrity of myofibers. Damaged muscle cells degenerate
and undergo necrosis, and are ultimately replaced by
adipose and fibrous tissues. This results in the loss of
mobility and reduced life expectancy.
A number of pathogenic mutations have been discov-
ered in the dystrophin gene (DMD) of dogs. Examples
include a 4 base pair (bp) deletion in exon 65 in a
Cocker spaniel [4], an intron 13 long interspersed nu-
clear element (LINE-1) insertion in the Pembroke WelshCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Jenkins and Forman Canine Genetics and Epidemiology  (2015) 2:7 Page 2 of 4Corgi [3], and a splice site mutation in the golden re-
triever resulting in the skipping of exon 7 [5].
A six month old Norfolk terrier was referred to the
Animal Health Trust neurology department displaying
clinical signs of muscular dystrophy (Figure 1), which
was confirmed through a full neurological and histo-
pathological work-up as described previously [6]. The
aim of this study was to identify the causal mutation for
the Norfolk terrier lacking functional dystrophin protein.
Due to the large size of the dystrophin gene we
focused our investigation on the 79 coding exons of
DMD. PCR primers were designed, and amplification
carried out individually for each exon using DNA from
the case and its dam. The PCR products were pooled
and libraries prepared for sequencing on the Ilumina
MiSeq platform. The dataset of 100 bp single-end reads
generated were aligned to the canine reference sequence
(canfam3). Sequence read alignments were visualised in
IGV [7]. A 1 bp deletion was identified in exon 22
(Figure 2). The deletion was heterozygous in the car-
rier (dam) and homozygous in the case. Analysis of the
predicted amino acid sequence of the protein sug-
gested that this mutation would cause a frameshift and
a premature stop codon (p.Gly1029AspfsX30) [Gen-
Bank:NM001003343], resulting in protein truncation.
To investigate the effect of the mutation on the level
of DMD gene expression, relative quantification by
quantitative reverse transcription PCR (qRT-PCR) was
performed. Assays were designed for the DMD gene and
for the ubiquitously expressed TATA box binding protein
(TBP) gene. RNA was extracted from skeletal muscle
samples obtained from one case and five control dogs.
Muscle samples were not matched by breed or the
muscle from which they were biopsied. qRT-PCR was
carried out in triplicate, and reaction efficiencies calcu-
lated by generating a seven point, doubling dilutionFigure 1 Photographs (A and B) depicting gross phenotype of the affecte
skeletal muscle atrophy with adduction of the hocks.standard curve for both assays [8]. Results indicated a
2.64 fold reduction in muscle DMD expression in the
DD-MD case (Figure 3b, Additional file 1), suggestive of
nonsense mediated decay.
To further investigate the effect of the mutation, west-
ern blot analysis was carried out. Protein was extracted
from skeletal muscle from the case, and compared to
protein extracted from two unaffected dogs’ skeletal
muscle. The primary antibody used for the western blot
(ab131315) targeted a region close to the N-terminus of
the dystrophin protein. The immunoblot showed bands
for full length dystrophin in both of the controls, but
not in the case (Figure 3a). This confirms that the case
lacks functional full length dystrophin. No band was
observed for the predicted truncated protein (approxi-
mately 122.4 kDa) caused by the mutation.
In the clinical investigation by Beltran and colleagues,
immunohistochemical analysis using antibodies targeting
the rod-domain and the c-terminus showed an absence
of dystrophin in the skeletal muscle of the Norfolk
terrier DD-MD case [6]. These findings are consistent
with the frameshift mutation identified in this study, as
the predicted truncated protein would lack both the
rod-domain and c-terminus. The western blot antibody
used in this study targeted a region close to the
N-terminus (amino acids 410–450) upstream of the
frameshift mutation discovered by exon resequencing.
No full-length dystrophin protein was identified by im-
munoblot in the affected dog, consistent with the genetic
findings. However, there was also no truncated dys-
trophin protein observed. Although the qPCR analysis
showed a 2.64 fold reduction in transcript levels, gene
expression was not knocked out completely. Conse-
quently, nonsense mediated decay of the mRNA does
not completely explain the absence of a shortened pro-
tein. We speculate that this may be due to cellulard six month old male Norfolk Terrier. The affected has generalised
Figure 2 Graphical display of the 1 bp deletion in DMD. Exon 22 sequence read alignments for the case (top) and obligate carrier (bottom). The
vertical solid grey bars represent the read depth and the horizontal grey bars represent aligned sequence reads with differences to the reference
sequence highlighted. The position of the 1 bp deletion is highlighted by the two vertical black lines. The black horizontal lines in the sequence
reads represent the deleted base, which is absent in case sequence reads and present in approximately half of the reads for the carrier.
A B
Figure 3 Expression Analysis. A) Western blot analysis of skeletal muscle samples. Left panel shows detection of dystrophin by an antibody
targeting the N-terminal region (ab131315). Bands are visible for full length dystrophin (* predicted weight 427 kDa) for both of the control samples, but
not the DD-MD case. The right panel shows a Coomassie blue stained SDS-PAGE protein gel which was run in parallel, showing similar distribution and
intensity of bands for all three samples. B) Relative levels of DMD transcript in skeletal muscle samples demonstrated by qRT-PCR. The DD-MD case shows
a 2.64 fold lower expression of DMD transcript in comparison to five independent skeletal muscle controls. Error bars are based on standard deviation.
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of aberrant cellular proteins.
In this study we have successfully identified a novel
frameshift mutation causing a case of DD-MD in a
Norfolk terrier dog.
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